NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

BenzingaNov 19 21:19

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of CtDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

BusinesswireNov 19 21:15

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 16 04:55

Felicia Williams Joins NeoGenomics Board of Directors

BusinesswireNov 14 21:10

Express News | Felicia Williams Joins Neogenomics Board of Directors

BreakingsNov 14 21:10

Earnings Scheduled For November 14, 2024

BenzingaNov 14 16:32